-
Views
-
Cite
Cite
IN THIS ISSUE, Japanese Journal of Clinical Oncology, Volume 44, Issue 3, March 2014, Pages 1–2, https://doi.org/10.1093/jjco/hyu021
- Share Icon Share
Extract
Review Article
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials
The most clinically relevant data from breast cancer treatment clinical trials are summarized. Biological predictive markers, and the safety and efficacy of common antiangiogenic therapies are also discussed.
Fakhrejahani, E. and Toi, M. Jpn J Clin Oncol 2014 44:3 197–207
Original Articles
Gastrointestinal Medicine
Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer
No standard regime is globally accepted in advanced gastric cancer. This study shows the combined regime of weekly liposome–paclitaxel plus S-1 is effective and tolerable in advanced gastric cancer.
Chen, L., Chen, Q., Zhuang, Z., et al. Jpn J Clin Oncol 2014 44:3 208–213
Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients
This large post-marketing survey confirms the clinical safety and effectiveness of panitumumab. The benefit/risk balance for panitumumab in Japanese patients with unresectable colorectal cancer remains favorable.